Osaic Holdings
LRMR icon

Osaic Holdings’s Larimar Therapeutics LRMR Stock Holding History

Osaic Holdings’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69K Hold
1,211
– – ﹤0.01% 7068
2026
Q1 		$5.45K Hold
1,211
– – ﹤0.01% 6646
2025
Q4 		$4.61K Buy
1,211
+211
+21% +$821 ﹤0.01% 6755
2025
Q3 		$3.62K Sell
1,000
-4,911
-83% -$18.4K ﹤0.01% 6920
2025
Q2 		$17.1K Sell
5,911
-1,000
-14% -$2.31K ﹤0.01% 5829
2025
Q1 		$14.9K Buy
6,911
+5,843
+547% +$18.5K ﹤0.01% 5560
2024
Q4 		$4.13K Buy
1,068
+68
+7% +$449 ﹤0.01% 6287
2024
Q3 		$6.55K Sell
1,000
-126
-11% -$1.01K ﹤0.01% 6081
2024
Q2 		$8.16K Buy
+1,126
New +$8.62K ﹤0.01% 5910
2023
Q4 		– Sell
-1,000
Closed -$3.95K – 7395
2023
Q3 		$3.95K Buy
+1,000
New +$3.78K ﹤0.01% 6372
2022
Q4 		– Sell
-800
Closed -$3K – 7331
2022
Q3 		$3K Buy
+800
New +$2K ﹤0.01% 6627
2022
Q2 		– Sell
-29
Closed – – 7495
2022
Q1 		$0 Hold
29
– – ﹤0.01% 7384
2021
Q4 		$0 Hold
29
– – ﹤0.01% 7489
2021
Q3 		$0 Buy
+29
New +$348 ﹤0.01% 7254

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Osaic Holdings's LRMR Position: Q2 2026 in Review

Osaic Holdings held its Larimar Therapeutics (LRMR) position steady in Q2 2026 at 1,211 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #7068.

Osaic Holdings first reported a position in LRMR in Q3 2021 and has held it in 14 quarters since. The position peaked at $17.1K in Q2 2025. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Osaic Holdings held 1,211 shares of Larimar Therapeutics worth $3.69K as of Q2 2026.
  • Osaic Holdings left its Larimar Therapeutics share count unchanged in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7068 holding.
  • Osaic Holdings first reported a position in Larimar Therapeutics in Q3 2021 and has held it in 14 quarters since.
  • Osaic Holdings's Larimar Therapeutics position peaked at $17.1K in Q2 2025.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.